Showing results (51-60 of 238) with videos related to
Sort By:
Pageof 24
Blut|October 1, 1979
[Detection of development of resistance in the short-term test (author's transl]M Volm, E MaassAnticancer Research|November 1, 1987
Clinical prognostic relevance of growth of human adenocarcinomas of the lung in nude miceM Volm, J MatternAnticancer Research|March 1, 1995
Associated expression of protein kinase C with resistance to doxorubicin in human lung cancerM Volm, E W PommerenkeIn Vivo (Athens, Greece)|March 1, 1995
Reversal of doxorubicin-resistance in solid tumors by clomipramineE W Pommerenke, M VolmCancer|August 15, 1992
Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transferase-pi in human lung tumorsM Volm, J Mattern, B SamselBritish Journal of Cancer|March 4, 1998
Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomasM Volm, W Rittgen, P DringsStrahlentherapie|January 1, 1980
[Irradiation of solid Walker carcino-sarcomas after synchronisation with hydroxyurea (author's transl)]K Wayss, J Mattern, M VolmInternational Journal of Cancer|February 20, 1997
Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancerM Volm, R Koomägi, J MatternAnti-Cancer Drugs|February 1, 1997
Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatinU Masanek, G Stammler, M VolmBritish Journal of Cancer|April 1, 1996
Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinomaJ Mattern, R Koomägi, M VolmPageof 24